NASDAQ:AEMD
Aethlon Medical Stock News
$1.42
-0.0050 (-0.352%)
At Close: Apr 18, 2024
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
12:00am, Sunday, 09'th Aug 2020
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Update
02:54am, Tuesday, 07'th Jul 2020
Aethlon Medical, Inc. (NASDAQ:AEMD) was the target of a large growth in short interest in June. As of June 30th, there was short interest totalling 283,800 shares, a growth of 17.2% from the June 15th
Edited Transcript of AEMD earnings conference call or presentation 25-Jun-20 8:30pm GMT
01:21pm, Tuesday, 30'th Jun 2020
Q4 2020 Aethlon Medical Inc Earnings Call
Aethlon Medical, Inc. 2020 Q4 - Results - Earnings Call Presentation
01:45pm, Friday, 26'th Jun 2020Aethlon Medical, Inc. (AEMD) CEO Timothy Rodell on Q4 2020 Results - Earnings Call Transcript
08:21pm, Thursday, 25'th Jun 2020
Aethlon Medical, Inc. (NASDAQ:AEMD) Q4 2020 Earnings Conference Call June 25, 2020 4:15 P.M. ET Company Participants James Frakes - Chief Financial Officer and
Aethlon Medical Announces Fiscal Year Financial Results and Provides Corporate Update
08:15pm, Thursday, 25'th Jun 2020
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today reported financial results for
Aethlon Medical, Inc. to Host Earnings Call
06:30pm, Thursday, 25'th Jun 2020
NEW YORK, NY / ACCESSWIRE / June 25, 2020 / Aethlon Medical, Inc. (NASDAQ:AEMD) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on June 25, 2020 at 4:30
Aethlon Medical Presents Hemopurifier® Data at the American Association for Cancer Research 2020 Annual Meeting
12:31pm, Monday, 22'nd Jun 2020
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in viral diseases, oncology and inflammation, today released positive ex vivo data demo
The Week Ahead In Biotech: Karyopharm, Zogenix, Heron, Chiasma On The Radar Ahead Of FDA Decisions
12:00am, Sunday, 21'st Jun 2020
Biotech stocks rebounded along with the broader market in the week ended June 19. The week was a busy one from the perspective of PDUFA dates, with the FDA issuing approvals...
U.S. FDA backs testing of Aethlon device for virus treatment - BNN Bloomberg
05:20pm, Thursday, 18'th Jun 2020
Aethlon reported that U.S. regulators cleared the company to run a feasibility study of its investigational device in as many as 40 patients under intensive care for severe COVID-19.
FDA Backs Testing of Device Once Flagged for Covid Speculation
04:49pm, Thursday, 18'th Jun 2020
(Bloomberg) -- As far back as January, stock traders were latching onto Aethlon Medical Inc. and its experimental Hemopurifier device as a potential treatment for the novel coronavirus. After shares q
Aethlon Announces FDA Approval of IDE Supplement for COVID-19 Patients
01:20pm, Thursday, 18'th Jun 2020Aethlon Announces FDA Approval of IDE Supplement for COVID-19 Patients
01:19pm, Thursday, 18'th Jun 2020
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in viral diseases, oncology and inflammation, announced today that the U.S. Food and Dr
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.15%
12:00am, Thursday, 18'th Jun 2020
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.15%
Aethlon Medical To Release Fourth Quarter Financial Results and Host Conference Call on June 25, 2020
12:30pm, Tuesday, 16'th Jun 2020
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its fourth quarter fiscal ye
